CHO cell line development
For a complex recombinant protein a microbial host is not enough. CHO cell line development is the path from the gene to the stable, documented clonal line that production can rest on: vector, stable pools, clone selection, cell bank.
Talk to us about your proteinWhen a mammalian line is the answer
A CHO line is not a more expensive alternative to microbial expression: it answers requirements a microbial host cannot meet at all.
The protein E. coli cannot make
Size, disulfide bonds, glycosylation, post-translational modification. Where the microbial host does not reach, a mammalian line is the right answer rather than a fallback.
You need a clonal line, not a pool
A stable pool is enough for early material. Production needs a single clone, characterised and with its history documented.
You have to demonstrate stability
Expression held over generations, and a bank to start again from. That is what separates a usable line from one that worked once.
How a project runs
Three stages, each ending in a decision rather than a report. How long each takes depends on the protein — we size it after the first conversation, not before.
Vector and stable pools
Gene design, cloning and sequence verification, then generation of stable pools and characterisation of the best of them. The output is the first answer on expressibility and the first material to work with.
Clone selection
From several hundred clones down through successive rounds to the few that get characterised properly, on productivity, product quality and behaviour in culture.
Stability and cell bank
Stability of the selected clones verified, fed-batch optimised, and the cell bank built that production will start again from.
What we measure
A line is chosen on the numbers, not on the first titre it gives. These are the endpoints we report.
- Titre — protein per litre, with the method declared
- Specific productivity — how much the single cell makes, which is what carries to scale
- Product quality — integrity and profile of the protein, not only the quantity
- Behaviour in culture — growth, viability and length of the batch
- Expression stability — held over generations, verified rather than assumed
- Clonality — documented to the level your regulatory route requires
- Fed-batch performance — the format production will actually run in
- Reproducibility — the same conditions repeated, with the spread declared
The laboratory behind it
Equipment
| Cell culture | CHO cell culture, from screening formats up to the 100-litre scale |
| Molecular biology | Gene design, cloning, sequence verification and characterisation of the clones |
| Analytics | SDS-PAGE, SEC, HPLC and UPLC, activity and quantification assays according to the protein |
What you take away
| Cell line | The selected pool or clone, characterised and with its performance documented |
| Cell bank | The bank production will start again from, with the checks performed |
| Dossier | Data, conditions tested and results, in the form your technical file needs |
Frequently asked questions
When the protein needs mammalian modifications, such as glycosylation, that a microbial host does not carry out.
A documented clonal line and its cell bank, starting from the vector and stable pools.
Because a production line has to derive, in a documented way, from a single cell.
Start with the protein
Tell us the sequence, what the protein has to do and the scale you are aiming at. We will tell you what the first stage would look like.
Talk to us about your protein